+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Low doses of ethanol decrease the activity of the angiotensin-converting enzyme in the aorta of aging rats and rats treated with a nitric oxide synthase inhibitor and dexamethasone



Low doses of ethanol decrease the activity of the angiotensin-converting enzyme in the aorta of aging rats and rats treated with a nitric oxide synthase inhibitor and dexamethasone



Clinical Science 122(2): 75-81



In the present study, the activity of ACE (angiotensin-converting enzyme) in the aorta of senescent rats and rats treated with the NOS (NO synthase) inhibitor L-NAME (NG-nitro-L-arginine methyl ester) or dexamethasone and the effect of low doses of ethanol (0.2-1.2 g/kg of body weight, daily for 8-12 days) on this activity were studied. We found that ACE activity increased with age and in response to L-NAME and dexamethasone treatment. Ethanol at a dose of 0.4 g/kg of body weight per day decreased ACE activity in the aorta of aged rats and of rats treated with L-NAME or dexamethasone to the level of activity in young control rats. The optimal ethanol dose (the dose inducing a maximum decrease in ACE activity) increased with increasing doses of dexamethasone: 0.4 g/kg of body weight per day at 30 μg of dexamethasone/kg of body weight and 0.8 g/kg of body weight per day at 100 μg of dexamethasone/kg of body weight. It was also found that optimal doses of ethanol increased the number of cells in the thymus of rats treated with dexamethasone. The optimal dose of ethanol of 0.4 g/kg of body weight per day, which induced a maximum decrease in ACE activity in rat aorta, corresponded to a dose of 30 g of ethanol/day, which, according to epidemiological data, produces a maximum decrease in the incidence of cardiovascular disease in humans. In conclusion, the decrease in ACE activity in vessels may be one of the main mechanisms of the beneficial effects of low doses of ethanol on human health.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054183938

Download citation: RISBibTeXText

PMID: 21767262

DOI: 10.1042/cs20110181


Related references

Effects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone. Age 35(6): 2089-2097, 2013

Chemiluminescence assay of nitric oxide release from kidneys of hypertensive rats treated with angiotensin converting enzyme inhibitor. Hypertension 26(3): 570, 1995

Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats. Circulation 104(8): 945-950, 2001

Gene expression of endothelin-1 and endothelial-type nitric oxide synthase in cardiovascular tissues of stroke-prone spontaneously hypertensive rats/Izm: effects of the angiotensin-converting enzyme inhibitor aracepril. Journal of Cardiovascular Pharmacology 31(Suppl. 1): S395-S398, 1998

Camel thorn extract reduces activity of angiotensin-converting enzyme in rat aorta increased during aging and treatment with NO-synthase inhibitor. Bulletin of Experimental Biology and Medicine 158(2): 222-224, 2014

Angiotensin-converting enzyme inhibitors and AT1-receptor antagonist restore nitric oxide synthase (NOS) activity and neuronal NOS expression in the adrenal glands of spontaneously hypertensive rats. Japanese Journal of Pharmacology 85(4): 365-369, 2001

Nitric oxide synthase inhibition prevents the decrease in angiotensin converting enzyme mRNA and activity by activated neutrophils in bovine pulmonary arterial endothelial cells. FASEB Journal 18(4-5): Abst 402 14, 2004

Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts. Hypertension Research 24(4): 403-409, 2001

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus. Circulation Journal 66(9): 811-815, 2002

Propofol increases vascular relaxation in aging rats chronically treated with the angiotensin-converting enzyme inhibitor captopril. Anesthesia and Analgesia 116(4): 775-783, 2013

Angiotensin Converting Enzyme Inhibitor Enhances Generation of Nitric Oxide in the Kidney of Dahl Salt-Sensitive Rats with Hypertension. Circulation 90(4 Part 2): I343, 1994

Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist. Journal of Hypertension 13(4): 439-445, 1995

The measurement of serum angiotensin i converting enzyme activity in rats treated with mk 421 an inhibitor. IRCS (International Research Communications System) Medical Science Library Compendium 9(7): 625, 1981

Plasma angiotensin converting enzyme activity and nitric oxide formation in diabetic Dahl rats. Clinical Research 41(4): 719A, 1993

Angiotensin type-1 receptor blockade upregulates the expression of endothelial nitric oxide synthase in hypertensive rat aorta by a mechanism differing from the upregulation induced by angiotensin converting enzyme inhibition. Circulation 90(4 Part 2): I34, 1994